Is Mevo Health legitimate? The care, price, and policy details

Understand the care arrangement

Mevo Health describes an online medical consultation before treatment is recommended. Its public material focuses on compounded semaglutide and tirzepatide injections and ongoing provider support. A patient should ask how often assessment occurs and how concerns reach the clinician between routine renewals.

Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.

Read the price in its proper context

The page lists semaglutide from $199 and tirzepatide from $259. It also offers monthly, quarterly, and six-month plan lengths. Ask which term produces the displayed amount and how much is due at enrollment; an as-low-as figure is incomplete without its payment period.

Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.

Find the cancellation boundary

The FAQ says a patient can cancel before the next billing cycle. That statement addresses a future renewal. Ask separately whether an existing longer commitment can be refunded and what happens to medication already ordered or prepared for the current cycle.

A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.

Identify the actual prescription

Mevo describes compounded preparations supplied by licensed US pharmacies. Obtain the assigned dispenser’s name and the exact label information. Licensing and prescribing review are relevant checks, but neither constitutes FDA approval of a compounded medicine.

FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.

Contact and account help

Mevo Health’s published contact number is (845) 570-3714. The documented email route is care@mevohealth.com.

Published care contact; a general support reply is not an emergency service.

Start from the official Mevo Health website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.

Bring one concrete question to the consultation

Which plan length produces my quoted price, and what financial obligation remains if the clinician changes treatment before that term ends?

Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.

Source notes

Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.

1. Online GLP-1 Weight Loss | Board-Certified Physicians | Mevo Health ↗Provider-published information · Checked September 22, 2026
2. FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
3. FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026